Jci_page_head_homepage_01 Jci_page_head_homepage_02
George T. De Sanctis, James A. MacLean, Shixin Qin, Walter W. Wolyniec, Hartmut Grasemann, Chandri N. Yandava, Aiping Jiao, Thomas Noonan, Joan Stein-Streilein, Francis H.Y. Green, Jeffrey M. Drazen
Published in Volume 103, Issue 4
J Clin Invest. 1999; 103(4):507–515 doi:10.1172/JCI4017
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1

Schematic representation of the sensitization and challenge protocols. For the acute challenge protocol (a), mice were sensitized and boosted on days 1 and 7 with OVA, received a single aerosol challenge of either OVA or PBS on day 14, and were studied on day 15. For the chronic challenge protocol (b), mice were sensitized and boosted on days 1 and 7, received repeated aerosol challenge of either OVA or PBS on days 14–20, and were studied on day 21. IP, intraperitoneally; OVA, ovalbumin.